Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,732
  • Shares Outstanding, K 21,043
  • Annual Sales, $ 7,190 K
  • Annual Income, $ -50,080 K
  • EBIT $ -42 M
  • EBITDA $ -41 M
  • 60-Month Beta 0.35
  • Price/Sales 1.48
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.89
  • Most Recent Earnings $-0.57 on 11/14/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 119.92%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 0.00% on 12/06/24
  • IV Low 0.00% on 12/06/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 200
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 9,200
  • Open Int (30-Day) 9,198

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +1,427,242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4156 +25.12%
on 11/21/24
0.7000 -25.71%
on 12/02/24
-0.0599 (-10.33%)
since 11/08/24
3-Month
0.4156 +25.12%
on 11/21/24
2.8394 -81.69%
on 09/10/24
-2.1600 (-80.60%)
since 09/09/24
52-Week
0.4156 +25.12%
on 11/21/24
8.3799 -93.79%
on 12/28/23
-3.2400 (-86.17%)
since 12/08/23

Most Recent Stories

More News
T2 Biosystems Announces Licensing Plans to Enhance Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

T2 Biosystems announced plans to license its technology for direct-from-whole-blood detection of sepsis-causing pathogens, aiming to expand market access.Quiver AI SummaryT2 Biosystems, Inc. has announced...

TTOO : 0.5200 (+1.96%)
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

TTOO : 0.5200 (+1.96%)
T2 Biosystems: Q3 Earnings Snapshot

T2 Biosystems: Q3 Earnings Snapshot

TTOO : 0.5200 (+1.96%)
T2 Biosystems Announces Third Quarter 2024 Financial Results

TTOO : 0.5200 (+1.96%)
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

TTOO : 0.5200 (+1.96%)
What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

XLV : 144.70 (+0.29%)
$SPX : 6,052.85 (-0.61%)
TTOO : 0.5200 (+1.96%)
CAH : 121.58 (-0.96%)
T2 Biosystems to Host Business Update Call on October 10, 2024

TTOO : 0.5200 (+1.96%)
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

TTOO : 0.5200 (+1.96%)
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

TTOO : 0.5200 (+1.96%)
CAH : 121.58 (-0.96%)
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results

TTOO : 0.5200 (+1.96%)

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens,...

See More

Key Turning Points

3rd Resistance Point 0.5773
2nd Resistance Point 0.5587
1st Resistance Point 0.5393
Last Price 0.5200
1st Support Level 0.5013
2nd Support Level 0.4827
3rd Support Level 0.4633

See More

52-Week High 8.3799
Fibonacci 61.8% 5.3375
Fibonacci 50% 4.3977
Fibonacci 38.2% 3.4580
Last Price 0.5200
52-Week Low 0.4156

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar